About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Phoenix | 197 Studies

Clinical Trials Breast CancerPhoenix

Breast Cancer Clinical Trials in Phoenix

Find 197 clinical trials for breast cancer near Phoenix, Arizona. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-197 of 197 trials

CompletedS9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast CancerRATIONALE: Telephone counseling by breast cancer survivors may enhance the well-being and quality of life of women who have recurrent breast cancer.NCT00031772·Birmingham, Alabama and 108 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingTesting Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast CancerThis randomized phase II trial studies how well olaparib with or without atezolizumab work in treating patients with non-HER2-positive breast cancer that has spread to nearby…NCT02849496·Phoenix, Arizona and 57 others

CompletedPhase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast CancerThe purpose of this study was to determine the effects of the weekly regimen of ixabepilone dosing compared to the once every 3 week dosing regimen in participants with metastatic…NCT00593827·Birmingham, Alabama and 56 others

Active not recruitingA Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast CancerThe main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cancer that is estrogen receptor…NCT05514054·Daphne, Alabama and 671 others

CompletedRadiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective for bone metastases.NCT00003162·Birmingham, Alabama and 252 others

Active not recruitingDeveloping an Internet-Delivered Sexual Health Program for Breast Cancer Survivors, SHINE TrialThe goal of this clinical trial is to develop an effective internet-delivered program to help breast cancer survivors manage cancer-related sexual concerns.NCT06216574·Phoenix, Arizona and 235 others

CompletedS9630, Medroxyprogesterone in Treating Women With Breast CancerRATIONALE: It is not yet known whether medroxyprogesterone is effective in preventing endometrial disorder in patients with breast cancer who are taking tamoxifen.NCT00002920·Mobile, Alabama and 121 others

Active not recruitingMobile Health for Adherence in Breast Cancer PatientsThis clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text…NCT06112613·Fairbanks, Alaska and 505 others

RecruitingBreast Cancer, Reasoning, and Activity InterventionThis phase II trial tests whether an exercise intervention works to improve cognitive function in breast cancer survivors.NCT04816006·Phoenix, Arizona

Active not recruitingStudy of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsThis is an open-label, multicenter Phase 1 study to evaluate safety, tolerability and preliminary efficacy of oral LY3410738 in patients with isocitrate dehydrogenase 1 (IDH1)…NCT04521686·Phoenix, Arizona and 32 others

Active not recruitingHormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)This randomized phase III trial studies the best individual therapy for women who have node-negative, estrogen-receptor positive breast cancer by using a special test (Oncotype…NCT00310180·Anniston, Alabama and 1221 others

TerminatedIsoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or LumpectomyRATIONALE: Eating a diet rich in soy foods may slow the progression of some types of cancer.NCT00036686·Phoenix, Arizona and 6 others

Active not recruitingSTOP-HER2: Stopping Trastuzumab in HER2+ MBCThis study is being done to see if anti-HER2 treatment be safely stopped in patients with HER2-positive metastatic breast cancer (MBC) that have had exceptional response to…NCT05721248·Phoenix, Arizona and 12 others

Active not recruitingNivolumab and Ipilimumab in Treating Patients With Rare TumorsThis phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors.NCT02834013·Birmingham, Alabama and 1006 others

TerminatedOral AMXT 1501 Dicaprate in Combination With IV DFMOA Phase 1B/2A study will be conducted to establish safety and dose level of AMXT 1501 dicaprate in combination with IV DFMO, in cancer patients.NCT05500508·Phoenix, Arizona and 6 others

CompletedCharacterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy IndexUtilizing CellSearch® technology, the ability to both enumerate and reliably and reproducibly characterize circulating tumor cells (CTC) for tumor markers that predict endocrine…NCT01701050·Phoenix, Arizona and 19 others

TerminatedNeoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast CancerThe investigators propose to influence estrogen receptor (ER) signaling by combining endocrine therapy with CDK4/6 inhibition along with trastuzumab in ER+/ human epidermal growth…NCT02907918·Phoenix, Arizona and 2 others

PreviousPage 10 of 10

Other Conditions in Phoenix

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma